SCHEMBL1706949

SCHEMBL1706949

CC(C)(C)C(=O)[C@@H](c1ccccc1)C(C)(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
HSP90AA1 P07900 1/20 0.44
MAPT P10636 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
CYP3A4 P08684 1/20 0.43
HIF1A Q16665 1/20 0.43
CYP2D6 P10635 1/20 0.41
SRC P12931 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 2/20 0.40
MAPK1 P28482 1/20 0.40
FFAR2 O15552 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
POLB P06746 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1703642 1.00 ATM (0.58) ATML3MBTL1HSP90AA1MAPTGPR55
SCHEMBL66018 0.83 L3MBTL1 (0.61) ATML3MBTL1CYP2D6SRCKMT2A
SCHEMBL17357501 0.83 L3MBTL1 (0.61) ATML3MBTL1CYP2D6SRCKMT2A
SCHEMBL8975800 0.81 L3MBTL1 (0.59) ATML3MBTL1CYP3A4CYP2D6SRC
SCHEMBL2416799 0.81 ATM (0.59) ATML3MBTL1MAPTCYP2D6SRC
SCHEMBL8870520 0.79 L3MBTL1 (0.58) ATML3MBTL1MAPTCYP2D6SRC
SCHEMBL10389938 0.79 L3MBTL1 (0.58) ATML3MBTL1MAPTCYP2D6SRC
SCHEMBL8462436 0.78 SRC (0.56) ATML3MBTL1HSP90AA1MAPTGPR55
SCHEMBL11241802 0.78 ATM (0.52) ATML3MBTL1HIF1ACYP2D6SRC
SCHEMBL409758 0.78 POLB (0.50) ATML3MBTL1HSP90AA1MAPTGPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10017522-B2 Alpha helix mimetics and methods relating thereto Prism BioLab Co., Ltd. (JP) 2018-07-10 US disclosed
US-20150368262-A1 ALPHA HELIX MIMETICS AND METHODS RELATING THERETO Prism BioLab Co., Ltd. (JP) 2015-12-24 US disclosed
US-9040531-B2 Alpha helix mimetics and methods relating thereto Prism BioLab Co., Ltd. (JP) 2015-05-26 US disclosed
US-20120088770-A1 ALPHA HELIX MIMETICS AND METHODS RELATING THERETO PRISM BIOLAB CORPORATION (JP) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368262-A1 ALPHA HELIX MIMETICS AND METHODS RELATING THERETO PLOD3, COL1A1, THPO ATM 3535/4885L3MBTL1 1413/4885HSP90AA1 53/4885
US-20120088770-A1 ALPHA HELIX MIMETICS AND METHODS RELATING THERETO PLOD3, COL1A1, THPO ATM 3535/4885L3MBTL1 1413/4885HSP90AA1 53/4885
US-10017522-B2 Alpha helix mimetics and methods relating thereto PLOD3, COL1A1, THPO ATM 3535/4885L3MBTL1 1413/4885HSP90AA1 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.